Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
25400
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Report on the monthly exercise status of the Third Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions)
発行・処分する株式数25,400Shares
Shares delivered during the month: 25,400 new shares; treasury shares transferred: —
発行済株式総数
Exercise ratio subject to exercise restrictions: 0.09% (25,400 shares delivered during the month for all series combined / 29,097,300 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices in April 2026: ¥379.3, ¥371.5, ¥374.5, ¥370.6 and ¥374.2. Details of the adjustment provisions and adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 38,431 (unexercised balance as of the end of the month under review; monthly exercise ratio against the total issued: 0.66%); unexercised balance: 38,431 (representing 3,843,100 shares)
Procedures under the Corporate Code of Conduct
The disclosure states the status of compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments.
Most recent equity financing
Timing 9 March 2026 / Type Issuance of the Third Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the monthly exercise status of the Third Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 25,400 new shares; treasury shares transferred: — |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 0.09% (25,400 shares delivered during the month for all series combined / 29,097,300 listed shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 29,146,200 shares (as of the end of the month preceding the month under review) → Not disclosed |
| Exercise price | Exercise prices in April 2026: ¥379.3, ¥371.5, ¥374.5, ¥370.6 and ¥374.2. Details of the adjustment provisions and adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 38,431 (unexercised balance as of the end of the month under review; monthly exercise ratio against the total issued: 0.66%); unexercised balance: 38,431 (representing 3,843,100 shares) |
| Procedures under the Corporate Code of Conduct | The disclosure states the status of compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments. |
| Most recent equity financing | Timing 9 March 2026 / Type Issuance of the Third Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions) / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company is reporting the monthly exercise status of the Third Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions) for April 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.